JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

A Biopsy-Controlled Prospective Study of Contrast-Enhancing Diffuse Glioma Infiltration Based on FET-PET and FLAIR

  • 0Department of Neurooncology and Radiosurgery, Franciszek Lukaszczyk Oncology Center, 85-796 Bydgoszcz, Poland.
Cancers +

|

April 13, 2024

|

April 13, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Defining glioma infiltration is challenging due to MRI limitations. New O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-PET analysis using early dual-timepoint imaging and choroid plexus background accurately identifies tumor extent beyond MRI-defined borders.

Area Of Science

  • Neuro-oncology
  • Radiology
  • Nuclear Medicine

Background

  • Glioma infiltration extent is difficult to define accurately with MRI, impacting radiotherapy and surgery.
  • Magnetic resonance imaging (MRI) often underestimates the true tumor spread, especially beyond contrast-enhancing regions.
  • O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-PET shows promise in revealing infiltration beyond MRI-apparent tumor boundaries.

Purpose Of The Study

  • To optimize O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-PET analysis protocols for accurately defining glioma infiltration.
  • To investigate FET uptake dynamics using dual-timepoint imaging to improve tumor delineation.
  • To establish optimal threshold values for differentiating tumor infiltration from normal brain structures.

Main Methods

  • Dual-timepoint (early and delayed) FET-PET imaging was performed in 23 glioma patients undergoing stereotactic biopsies.
  • Target-to-background ratios (TBRs) and standardized uptake values (SUVs) were calculated using various background structures, including contralateral brain and choroid plexus.
  • Biopsy samples from areas inside and outside contrast enhancement and FLAIR signal were analyzed to correlate with imaging findings.

Main Results

  • Standard FET-PET thresholding struggled to differentiate high-grade glioma from astrogliosis at the tumor border.
  • Using early FET-PET acquisition with choroid plexus as background significantly improved sensitivity (56% to 90%) and specificity (41% to 61%) for defining tumor infiltration within FLAIR.
  • This novel approach accurately identified tumor infiltration beyond current FET-PET protocol limitations.

Conclusions

  • Current FET-PET protocols for contrast-enhancing gliomas are limited in defining tumor borders, particularly distinguishing grade 2 glioma from astrogliosis.
  • Early FET-PET acquisition with choroid plexus uptake as background offers a superior strategy for precise glioma infiltration volume definition.
  • This optimized method enhances the accuracy of radiotherapy and surgical planning by better defining tumor extent.

Keywords: